US Patent Issued to Juno Therapeutics on March 17 for "Process for producing a composition of engineered T cells" (Washington Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,285, issued on March 17, was assigned to Juno Therapeutics Inc. (Seattle).

"Process for producing a composition of engineered T cells" was invented by Mirna Mujacic (Seattle), Ayu Rahardjo (Seattle), Pascal Beauchesne (Seattle), Kien Khuu-Duong (Seattle), Ivie Aifuwa (Seattle) and Calvin Chan (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods for genetically engineering T cells, such as CD4+ T cells and/or CD8+ T cells, for use in cell therapy. In some aspects, the provided methods include one or more steps for pooling enriched CD4+ and CD8+ cells, such as at a 1:1 ratio, and then incubating the cells un...